Back to Centiva Capital, LP

REGN
7 quarters

Position history for Centiva Capital, LP's holdings in REGENERON PHARMACEUTICALS

Centiva Capital, LP holds 14,610 shares of REGN (REGENERON PHARMACEUTICALS), worth $11.3M as of 2026-Q1. This is a new position. REGN represents 0.1% of Centiva Capital, LP's portfolio.

Current Value

$11.3M

Current Shares

14,610

Total Value Change

+$11.2M

Total Shares Change

+14,544

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
New
14,610
-
$11.3M0.1%$766.66
38
2025-Q3
Exited
0
-100.0%
$00.0%$560.05
0
2025-Q2
New
431
-
$226,2750.0%$519.56
32
2025-Q1
Exited
0
-100.0%
$00.0%$634.66
0
2024-Q4
New
604
-
$430,2470.0%$698.71
33
2024-Q3
Exited
0
-100.0%
$00.0%$1,036.94
0
2024-Q2
Decreased
66
-86.5%
$69,3680.0%$1,045.23
0

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used